BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37909116)

  • 1. Resveratrol affects ccRCC cell senescence and macrophage polarization by regulating the stability of CCNB1 by RBM15.
    Chen Z; Liu C; Ye T; Zhang Y; Chen Y
    Epigenomics; 2023 Sep; 15(18):895-910. PubMed ID: 37909116
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
    Zeng X; Chen K; Li L; Tian J; Ruan W; Hu Z; Peng D; Chen Z
    Free Radic Biol Med; 2022 May; 184():135-147. PubMed ID: 35381326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.
    Liang J; Zhang Y; Jiang G; Liu Z; Xiang W; Chen X; Chen Z; Zhao J
    Oncol Res; 2013; 21(2):83-91. PubMed ID: 24406044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.
    Shen T; Miao S; Zhou Y; Yi X; Xue S; Du B; Tang C; Qu L; Fu D; Jia R; He H
    Cell Commun Signal; 2022 Sep; 20(1):152. PubMed ID: 36153596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion.
    Wang C; Piao C; Liu J; Zhang Z; Zhu Y; Kong C
    Cancer Biomark; 2020; 29(4):453-462. PubMed ID: 32675395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.
    Xu Y; Li L; Yang W; Zhang K; Zhang Z; Yu C; Qiu J; Cai L; Gong Y; Zhang Z; Zhou J; Gong K
    J Exp Clin Cancer Res; 2023 Jul; 42(1):159. PubMed ID: 37415241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
    Huang S; Hou Y; Hu M; Hu J; Liu X
    BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
    Fu Y; Piao C; Zhang Z; Zhu Y; Sun S; Bi J; Kong C; Ju M
    Urol Oncol; 2020 Sep; 38(9):740.e1-740.e9. PubMed ID: 32402768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits the progression of premature senescence partially by regulating v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA) and sirtuin 1 (SIRT1).
    He S; Zhou M; Zheng H; Wang Y; Wu S; Gao Y; Chen J
    Ren Fail; 2022 Dec; 44(1):171-183. PubMed ID: 35166167
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
    Gong Q; Jiang Y; Xiong J; Liu F; Guan J
    Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA ITCH Is a Tumor Suppressor in Clear Cell Renal Cell Carcinoma Metastasis through miR-106b-5p/PDCD4 Axis.
    Gao P; Huang Y; Hou Y; Li Q; Wang H
    J Immunol Res; 2021; 2021():5524344. PubMed ID: 33969128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
    Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
    Kawakami I; Yoshino H; Fukumoto W; Tamai M; Okamura S; Osako Y; Sakaguchi T; Inoguchi S; Matsushita R; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    Biochem Biophys Res Commun; 2022 Jun; 611():99-106. PubMed ID: 35487063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNHG16 promotes cell proliferation and inhibits cell apoptosis via regulation of the miR-1303-p/STARD9 axis in clear cell renal cell carcinoma.
    Cheng T; Shuang W; Ye D; Zhang W; Yang Z; Fang W; Xu H; Gu M; Xu W; Guan C
    Cell Signal; 2021 Aug; 84():110013. PubMed ID: 33901578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.